Mesoporous silicon systems for oral protein: peptide-based diabetes mellitus therapy

Neha Shrestha

Forskningsoutput: AvhandlingDoktorsavhandlingSamling av artiklar

Originalspråkengelska
UtgivningsortHelsinki
Förlag
Tryckta ISBN978-951-51-2039-7
Elektroniska ISBN978-951-51-2040-3
StatusPublicerad - 2016
MoE-publikationstypG5 Doktorsavhandling (artikel)

Vetenskapsgrenar

  • 3121 Inre medicin
  • 317 Farmaci

Citera det här

Shrestha, N. (2016). Mesoporous silicon systems for oral protein: peptide-based diabetes mellitus therapy. Helsinki: University of Helsinki.
Shrestha, Neha. / Mesoporous silicon systems for oral protein : peptide-based diabetes mellitus therapy. Helsinki : University of Helsinki, 2016. 73 s.
@phdthesis{2afa53b9f0ac4b23a45b3f285bd91487,
title = "Mesoporous silicon systems for oral protein: peptide-based diabetes mellitus therapy",
keywords = "3121 Internal medicine, 317 Pharmacy",
author = "Neha Shrestha",
year = "2016",
language = "English",
isbn = "978-951-51-2039-7",
series = "Dissertationes Scholae Doctoralis Ad Sanitatem Investigandam Universitatis Helsinkiensis",
publisher = "University of Helsinki",
number = "21/2016",
address = "Finland",

}

Mesoporous silicon systems for oral protein : peptide-based diabetes mellitus therapy. / Shrestha, Neha.

Helsinki : University of Helsinki, 2016. 73 s.

Forskningsoutput: AvhandlingDoktorsavhandlingSamling av artiklar

TY - THES

T1 - Mesoporous silicon systems for oral protein

T2 - peptide-based diabetes mellitus therapy

AU - Shrestha, Neha

PY - 2016

Y1 - 2016

KW - 3121 Internal medicine

KW - 317 Pharmacy

M3 - Doctoral Thesis

SN - 978-951-51-2039-7

T3 - Dissertationes Scholae Doctoralis Ad Sanitatem Investigandam Universitatis Helsinkiensis

PB - University of Helsinki

CY - Helsinki

ER -

Shrestha N. Mesoporous silicon systems for oral protein: peptide-based diabetes mellitus therapy. Helsinki: University of Helsinki, 2016. 73 s. (Dissertationes Scholae Doctoralis Ad Sanitatem Investigandam Universitatis Helsinkiensis; 21/2016).